This workshop, organised by our EMCR Committee, is part of a series focusing on research translation and commercialisation.
Mark your calendars! On Sunday, 30th November 2025, we invite you to participate in a day full of knowledge and networking at the Medical Sciences Precinct, University of Tasmania. The event is scheduled from 12 PM to 5 PM AEDT, and we can’t wait to share this experience with you!
The Cerebrovascular Biology Australasia (CVBA) EMCR Committee successfully hosted a seminar, featuring Dr. Adam Edwards from the Perron Institute.
In his presentation, “From Preclinical Discovery to Commercialisation: Lessons from Translating Neuroprotective Therapies,” Dr. Edwards discussed the journey from scientific discovery to commercialization in neuroprotection. He shared his experiences translating preclinical research into the therapeutic ARG-007 for acute ischemic stroke, highlighting the complexities of validation, regulatory requirements, and industry partnerships. Drawing from his roles at the Perron Institute and Argenica Therapeutics, he provided insights into translational research challenges and strategies for effective industry engagement, offering valuable lessons for EMCRs aiming to connect academic discoveries with commercial applications in biomedical sciences.
The Cerebrovascular Biology Australasia (CVBA) EMCR Committee hosted a seminar featuring Dr. Jereme Spiers from La Trobe University.
Jereme is an early career neuroscientist studying neuroinflammation and neurodegeneration. His PhD at The University of Queensland focused on neuroinflammatory oxidative stress, and he developed expertise in isolating rodent brain regions for molecular analysis. After working at the Medical Research Council Toxicology Unit in the UK on prion disease, he joined La Trobe University in 2018 to study extracellular vesicles (EVs) released from neurons and glia. Jereme specializes in EV techniques and investigates their role in neuroinflammation related to neurodegenerative diseases. He is now part of the Clear Vision Research Group at the Australian National University, focusing on identifying RNA and protein changes in specific brain cell types during disease progression.
Our first attempt to hold a symposium by virtually linking 7 satellite sites across Auckland, Brisbane, Newcastle, Melbourne, Hobart, Adelaide, and Perth was a huge success. Thanks to our generous sponsors, we hosted Prof. Neil Spratt as the plenary speaker and featured over 40 oral presentations, showcasing our members’ cutting-edge research.
The Cerebrovascular Biology Australasia (CVBA) EMCR Committee successfully hosted a seminar, featuring Dr Matilde Balbi from Queensland Brain Institute (40-Hz Optogenetic stimulation rescues functional synaptic plasticity after stroke; and, Dr Jemima Dzator from Griffith University (Exploring associations between cerebrovascular function and the expression of genes that may influence endothelial function in hormonal migraine).
